• SENSEX 79,809.65
    -270.92 (--0.34%)
  • BANKNIFTY 53,655.65
    -164.70 (--0.31%)
  • Ola Electric
    53.70 39.58(%)
  • N S D L
    1,226.05 880.00(%)
  • AAVAS Financiers
    1,518.00 1,533.20(%)
  • Waaree Energies
    3,352.25 1,808.65(%)
  • Bharat Electron
    371.10 435.95(%)
  • Godfrey Phillips
    11,400.00 11,462.00(%)
  • Apollo Micro Sys
    271.60 254.75(%)
  • Sammaan Capital
    126.75 174.00(%)
  • Reliance Industr
    1,350.30 1,115.55(%)
  • TCS
    3,077.00 2,992.05(%)
  • Infosys
    1,467.50 1,307.10(%)
  • Jio Financial
    316.70 363.00(%)
  • CG Power & Ind
    699.70 874.50(%)
  • M & M
    3,186.60 2,360.45(%)
  • Maruti Suzuki
    14,850.80 14,940.65(%)
  • Vikram Solar
    334.50 334.05(%)
  • Sun Pharma.Inds.
    1,601.40 1,960.20(%)
  • Vardhman Textile
    422.25 362.60(%)
  • Tata Motors
    668.00 542.55(%)
  • Dr Reddy's Labs
    1,265.65 1,413.97(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Balaxi Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 22472.0
  • ISIN : INE618N01022
45.85 0 (0.53%)
  • As on 29 Aug 2025 (EOD)

  • Today’s Low

    45.18

  • Today’s High

    46.85

  • Open

    45.49

  • Perv Close

    45.61

  • 52W Low

    42.56

  • 52W High

    127.45

Key Indicators

  • P/E(TTM)

    104.20

  • Mar.Cap (₹Cr.)

    253.13

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.16

  • Debt-Equity Ratio

    0.53

  • AGM Date

    29-Aug-2025

  • EPS

    0.44

  • P/E Ratio

    104.20

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    253.13

  • RONW (%)

    -25.94

  • ROCE (%)

    20.69

Score Board

  • Equity (₹ in Cr.)

    11.04

  • BV (₹)

    23.20

  • Sales( ₹ in Cr.)

    60.99

  • NP (in Cr.)

    3.60

  • NP Var(%)

    -2.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    251.80

  • 52 Week High

    127.45

  • 52 Week Low

    42.56

  • Price BSE

    0.0

  • Price NSE

    46.00

  • Market Capital( in Cr.)

    251.80

  • P/C Ratio

    62.60

  • P/E Ratio

    70.50

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 60.99 70.20 108.14 101.29 86.87 45.63
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 60.99 70.20 108.14 101.29 86.87 45.63
Other Income 5.37 2.40 6.60 2.75 1.81 0.59
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 66.36 72.60 114.74 104.04 88.68 46.22
EXPENDITURE :            
Raw Materials 50.94 56.49 82.10 76.92 63.33 32.83
Power and Fuel Cost 0.04 0.04 0.04 0.02 0.00 0.00
Employee Cost 4.87 5.04 4.04 2.90 1.95 1.75
Other Manufacturing Expenses 0.24 0.21 0.25 0.13 0.12 0.00
Selling and Administration Expenses 1.97 2.58 4.51 3.79 2.06 1.71
Miscellaneous Expenses 0.32 0.49 0.33 0.23 0.39 0.69
Employee Benefit Expenses 4.87 5.04 4.04 2.90 1.95 1.75
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 58.38 64.84 91.27 83.99 67.85 36.99
Operating Profit 7.98 7.75 23.48 20.05 20.83 9.24
Interest 2.24 1.66 0.51 0.10 0.15 0.05
Gross Profit 5.74 6.09 22.97 19.95 20.68 9.19
Depreciation 0.46 0.51 0.52 0.25 0.09 0.01
Profit Before Tax 5.28 5.58 22.45 19.70 20.59 9.18
Current Tax 1.78 2.04 5.17 5.00 5.46 2.69
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.10 -0.11 1.06 0.03 0.00 0.00
Reported Net Profit 3.60 3.65 16.22 14.67 15.13 6.50
Extraordinary Items 0.00 -0.04 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.60 3.69 16.22 14.67 15.13 6.50
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 55.99 52.34 36.61 21.95 6.81 0.32
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.50 0.00 0.00 0.00
P & L Balance carried down 59.59 55.99 52.34 36.61 21.95 6.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 5.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.50 0.00 0.00
Earnings Per Share-Unit Curr 0.65 0.67 15.93 14.67 15.13 6.50
Earnings Per Share(Adj)-Unit Curr 0.65 0.13 3.19 2.93 3.03 1.30
Book Value 23.16 21.61 80.35 57.91 43.25 28.11
Book Value(Adj)-Unit Curr 23.16 4.32 16.07 11.58 8.65 5.62

Shareholding Pattern

  • Promoter Group

    65.99%

  • Public Share Holding

    34.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,000,000 63.40 35,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,431,770 2.59 1,431,770 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,431,770 65.99 36,431,770 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,160 0.02 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,894,544 8.87 4,894,544 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,907,704 8.89 4,894,544 5
2] Non Institution
Bodies Corporate 2,317,380 4.20 2,317,380 53
Clearing Members 50 0.00 50 1
Directors of their Relatives 1,068,795 1.94 1,068,795 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 201,782 0.37 201,782 111
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 200,571 0.36 200,571 154
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,915,330 3.47 1,915,330 7
Individuals holding nominal share capital up to Rs. 1 lakh 6,997,362 12.67 6,859,912 13,399
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,166,756 2.11 1,166,756 2
Sub Total 13,868,026 25.12 13,730,576 13,729
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 55,207,500 100.00 55,056,890 13,737

Company Background

Balaxi Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Balaxi Pharmaceuticals Ltd
  • BSE Code : 22472.0
  • ISIN : INE618N01022

  • Incorporation Year

    1942

  • Registered Office

    41/298-D2 2nd Flr Saniya Plaza
    Mahakavi Bharatiyar Road, Cochin,
    Kerala-682035

  • Telephone

    91-484-4032952/6596725

  • FAX

  • Chairman

  • Managing Director

    Ashish Maheshwari

  • Company Secretary

    Mohith Kumar Khandelwal

  • Auditor

    P Murali & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    SKDC Consultants Ltd
    Surya 35 Mayflower ,
    Avenue Sowripalayam ,Road
    Mumbai - Coimbatore - 641 028

Balaxi Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Balaxi Pharma 45.85 66.36 60.99 104.20 5.06
Abbott India 31,497.70 6,684.73 6,409.15 46.09 44.95
Astrazeneca Phar 8,469.45 1,756.92 1,716.29 115.48 32.94
P & G Health Ltd 6,363.75 944.52 934.17 35.14 40.23
Glaxosmi. Pharma 2,783.45 3,866.05 3,723.49 50.05 58.72
Cipla 1,589.65 20,029.57 19,044.85 23.76 21.40
Amrutanjan Healt 688.80 437.58 421.23 36.52 20.84
Guj. Themis Bio. 377.90 152.47 150.80 92.40 27.21
Fermenta Biotec. 317.55 442.21 430.53 10.54 17.61
Bliss GVS Pharma 155.80 703.42 667.20 23.29 9.16
Ambalal Sarabhai 31.40 19.33 4.04 16.44 2.10